INmune Bio And Quantum Computing Inc. Partner To Use Quantum AI To Identify New Treatment Applications For Alzheimer’s Drug XPro

INmune Bio Inc. (NASDAQ: INMB) has partnered with Quantum Computing Inc. (NASDAQ: QUBT) to utilize quantum AI for identifying new treatment applications for its Alzheimer's drug XPro (XPro1595). This collaboration marks QCi's first commercial engagement in the pharmaceutical sector, combining INmune Bio's clinical research with QCi's Dirac-3S quantum optimization machine. The initiative aims to analyze clinical and biomedical datasets to uncover potential new indications and biomarkers for XPro, with possibilities for further collaboration as INmune Bio progresses in its clinical development.